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Summary.-Newborn mice have a lower spontaneous resistance to the growth of a
syngeneic plasmacytoma (MOPC-460) as compared to adult mice. The transfer of
different leucocyte populations from non-immunized adult donors to newborn mice
influence in a dual way the resistance to MOPC-460 growth, depending on the
number of cells transferred. The transfer of a low number of neutrophils, thymus
or spleen cells enhances the MOPC-460 takes. Higher numbers of neutrophils,
thymus or bone marrow cells induce an effective protection. By contrast, macro-
phages over a dose of 1 x 104 constantly produce a reduction of tumour growth.
THE DEVELOPMENT and growth of synge-
neic tumours is influenced in many cases
by the cell-mediated immunoreactivity
of the host organism. However, the
direction taken by such influence is not
always one way.
Although cellular-mediated resistance
to tumour development in vivo and cell-
mediated lysis of neoplastic cells in vitro
are general findings in several human and
experimental host-tumour systems (for
a review see Hellstrom and Hellstrom,
1974) there are several other situations in
which cellular-mediated enhancement of
tumour cell growth appears to take place
both in vitro (Prehn, 1972; Klein, 1972;
Fidler, 1973; Fidler, Brodey and Bech-
Nielsen, 1974; Kall and Hellstrom, 1975;
Nathan and Terry, 1975) and in vivo
(Belayev and Gruntenko, 1972; Fidler,
1974; Carnaud et al., 1974; Umiel and
Trainin, 1974). These contrasting find-
ings can be interpreted by the theory,
advanced by Prehn, that the effect of
immunity might be biphasic, that is, a
mild incipient immune response may be
stimulatory to tumour growth but a
strong one can be inhibitory (Prehn and
Lappe, 1971).
In an earlier paper, we showed that
newborn mice appear to have less spon-
taneous resistance than adults, to the
growth of transplantable tumours. The
minimum number of neoplastic cells
necessary for the induction of the same
percentage of tumours increased in a
parallel way with the post-natal develop-
ment of the immunocapability of the
recipient. The immunological nature of
the resistance shown by untreated adult
mice is supported by the fact that the
resistance to tumour growth shown by
heavily irradiated adult mice is identical
to that observed in neonatal mice. Thus
the lower resistance of the neonatal
animal seemed to be directly dependent on
its weaker immunological capability
(Forni and Comoglio, 1973).
The present study shows that the
transfer into newborn mice of different
numbers and types of leucocytes from
normal adult mice influences in different
ways the growth of a transplantable
syngeneic chemically induced plas-
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macytoma. Inhibition or enhancement
oftumour growth appears to be dependent
on the type and dose of cells transferred.
MATERIALS AND METHODS
Mice.-Brother-sister mated, inbred
Balb/c mice were used. This strain origi-
nated from the colony bred in the Animal
Production Branch of the National Institute
of Health (Bethesda, Md., U.S.A.). The
various groups of 20 newborn mice 8 to 12 h
old were randomly fostered from different
littermates.
Tumour.-An IgA plasmacytoma, MOPC-
460, chemically induced in the NIH Balb/c
strain, was used (Potter, 1967). The tumour
was transmitted to the newborn mice by s.c.
inoculations in the neck region of 3 x 104 live
cells, obtained by mechanical teasing, in
0-1 ml volume. Cell viability was deter-
mined by the trypan blue dye exclusion test
as described by Takahashi, Old and Boyse
(1970). Mice were periodically examined
for a period of80 days to determine the day of
tumour appearance. In all animal groups,
however, the percentage tumour take did not
change after the first 20 days.
Leucocyte suspension obtained from non-
immunized adult donors.-All single-cell sus-
pensions were prepared usingf as medium cold
Hanks' basal solution (HBSS) supplemented
with 10% foetal calf serum. Thymus cell
suspensions were obtained from 4-week-old
mice, the tissue being gently dissociated by
means of forceps. Spleens were minced with
scissors and passed through a 100-gauge
stainless-steel screen. Bone marrow cells
were flushed from femoral and tibial cavities
with cold medium using a syringe, and a
single-cell suspension was obtained by
repeated aspirations. Peritoneal exudate
cells were induced by i.p. inoculation of
1 ml of 0.8% beef heart infusion broth
fortified with 10% proteose peptone (No. 3,
Difco, Mich., U.S.A.). The cell population
containing more than 95% of neutrophils
as determined by morphological criteria
after May-Griinwald Giemsa staining was
obtained by washing the peritoneal cavity
4 h later (Kall and Hellstrom, 1975). Peri-
toneal macrophages were obtained by wash-
ing the peritoneal cavity 72 h after inocula-
tion of the above broth and by incubating
the cell suspension in plastic Petri dishes
(Falcon Plastic, Los Angeles) for 4 h at
37°C in 95% air and 5% CO2. Non-adherent
cells were then washed out and the adherent
cells, containing morethan 95% macrophages
capable ofingesting latex particles (Greineder
and Rosenthal, 1975) were removed from the
Petri dishes with a rubber policeman. All
the cell suspensions were allowed to stand
for 3 min at 4°C to permit settling of debris.
The supernatants, containing cells in suspen-
sion, were centrifuged twice at 400 g for
7 min at 4°C. The pellets were then sus-
pended in suitable concentrations in HBSS
without serum. All cell counts reported
refer to the viable cells as judged by the
exclusion of trypan blue. Only preparations
containing more than 85% viable cells were
used. The control preparations, containing
100% dead cells, were obtained by freezing
and thawing the various cell suspensions
4 times.
Statistical analysis.-The variation in
tumour take in every single experiment was
evaluated by using chi-squared analysis
with Yates' correction for small sample size.
RESULTS
Various groups of 20 8- to 12-h-old
animals were injected i.p. with 0-1 ml of
cell suspensions containing numbers of
cells ranging from 5 x 103 to 1 x 108
ofthe various kinds ofleucocytes obtained
from normal adult donors. Twenty-fourh
later all the newborn animal groups were
challenged s.c. with 3 x 104 living MOPC-
460 cells. This number of cells induces
about 50% of tumour take in newborn
animals and in heavily irradiated adult
mice, as determined in preliminary experi-
ments. On the other hand, when the
same dose was injected into untreated
adult animals older than 6 weeks, tumour
induction of only 10% was observed.
Progressive tumour growth and no regres-
sion was observed in all newborn and
adult animals in whom an initial pin-
point tumour was detected. However,
these tumours appear earlier and grow
faster in newborn and adult lethally
irradiated mice than in untreated adult
mice (Forni and Comoglio, 1973).
As can be seen in the Fig. which re-
ports the data ofa typical experiment, the
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FIG. Percentage of tumour incidence in
groups ofnewbornmice pre-inoculated with
increasing numbers ofleucocytes from adult
donors. Groups of 20, 8-12-h-old (new-
born) mice were inoculated i.p. with thy-
mus (A), bone marrow *), spleen cells
(*), neutrophils (LO1), or macrophages (0)
obtained from adult mice. Twenty-four h
after the injection, all groups were chal-
lenged s.c. with 3 x 104 MOPC-460 cells.
Hatched area: percentage of tumours +
s.e. mean in control groups pre-inoculated
with progressive doses of freeze-thawed
leucocytes and in groups not pre-inoculated
at all.
The points in the dotted area indicate
significant values (P 0-05 to < 0-001).
cumulative percentage of newborn mice
of various groups bearing progressively
growing tumours was strongly influenced
by the prior inoculation of living leuco-
cytes from normal adult donors. Peri-
toneal macrophages do not modify the
percentage take when less than 5 x 104
are injected, whilst a constant reduction
oftumour take is obtained after the trans-
fer of from 5 x 104 to 1 x 108 cells. A
similar protective pattern was observed
transferring up to 5 x 105 ofbone marrow
cells. By contrast, an enhancing effect
was observed with 5 x 103 spleen
cells.
Neutrophils and thymus cells showed
biphasic activity. The prior inoculation
of cell numbers ranging from 5 x 103 to
1 x 106 of peritoneal neutrophils, or
5 x 104 to 5 x 106 thymus cells resulted
in a marked increase of tumour take.
This enhancing effect on tumour
growth was however reversed when higher
doses of neutrophils and thymus cells
had been inoculated previously. When
cell numbers higher than 5 x 106 of
these cell types were injected, a consider-
able protection against tumour develop-
ment was observed. The protection given
to newborn mice by high doses of thymo-
cytes, bone marrow cells, neutrophils and
macrophages resulted in a frequency of
tumour take similar to that observed in
untreated adult animals. In contrast,
no substantial modification of tumour
incidence was obtained when higher
numbers of spleen cells were trans-
ferred.
Twenty-five control groups were simul-
taneouslypreinoculatedinasimilar manner
with logarithmic dilutions (from 5 x 103
to 5 X 107) of the different kinds of
leucocytes killed by freezing and thawing.
This transfer ofdifferent numbers ofkilled
cells failed to influence the percentage of
tumour take by more than ± 5%.
The experiment was repeated 3 times
and consistent increases and decreases in
percentage of tumour take were observed
in the various groups.
DISCUSSION
The findings obtained indicate that,
in the host-tumour model used, the
transfer of different doses of syngeneic
leucocytes from normal adult mice to
newborn mice can lead to -a biphasic
modification of final tumour incidence in
the recipients. In effect, both a block
and enhancement of tumour growth can
be induced by adoptive transfer of dif-
ference amounts of the same cell popula-
tion.
The tumour used in this study presents
tumour-specific and tumour-associated
antigens (Lynch et al., 1972; Comoglio
and Forni, 1973) which can be employed
to induce resistance in syngeneic animals.
Previous work also indicated that the take
and growth of this tumour is influenced
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by spontaneous or artificially induced
changes in host immune reactivity (Forni
and Comoglio, 1973). These data suggest
that MOPC-460 growth in syngeneic
animals is hindered by a spontaneously
induced mechanism of an immunological
type. In effect, the resistance to MOPC-
460 growth appears to increase in a parallel
way with the course of immunological
reactivity during postnatal development.
In this host-tumour system the resist-
ance adoptively transferred to the new-
born mice by sufficient numbers of
macrophages, neutrophils, thymus and
bone marrow cells from normal adult
donors is comparable with the spon-
taneous resistance displayed by the adult
mice challenged with the same number
of tumour cells. The fact that cytotoxic
activity against syngeneic tumour cells
can be observed with a variety ofdifferent
cells, such as macrophages (Evans and
Alexander, 1972), T lymphocytes (Rolling-
hoff and Wagner, 1973), B lymphocytes
(Lamon et al., 1973) and neutrophils
(Pickaver et al., 1972) is well established.
The marked blocking of tumour take
observed in this study by the adoptive
transfer in the newborn mice of high
doses of these cell populations from adult
mice suggests thattheinabilityofuntreated
newborns to reject tumours is related to a
lower number of these leucocyte types
and/or a decreased functional capability
ofthese cells in neonatal mice as compared
the adult mice.
Macrophages produce a constant reduc-
tion of tumour take over a range of
of 5 X 104 to 1 X 106 cells. It seems
feasible that the role of macrophages
(and bone-marrow-containing monocyte-
macrophage precursors) might be in anti-
gen processing or in increased availability
for effector function (specific or non-
specific), or both. In effect, a consider-
able body of evidence shows that the
immune defect in neonates can be repaired
by adult macrophages or their precursors
(Argyris, 1968; Blaese, 1975).
However, our data also demonstrate
an enhancement oftumour growth exerted
by some ofthese populations ofleucocytes
when transferredinlower numbers. With
peritoneal neutrophils and thymus cells, a,
stimulation ofMOPC-460 take was evident
when less than 5 X 106 cells were trans-
ferred. A tumour growth stimulation was
also observed with 5 x 103 spleen cells.
By contrast, no biphasic activity was
observed with peritoneal macrophages
and spleen cells.
The increased frequency of tumours
observed in the newborn recipients after
the transfer of low numbers of spleen,
neutrophils or thymus cells may be the
result of a mechanism oftumour immuno-
stimulation as proposed by Prehn (1972),
Prehn and Lappe (1971). An apparently
similar block or enhancement exerted by
different cell numbers has been reported in
several systems, both in vitro (Prehn,
1972; Klein, 1972; Fidler, 1973; Fidler,
Brodey and Bech-Nielsen, 1974; Kall and
Hellstrom, 1975; Nathan and Terry, 1975)
and in vivo (Belayev and Gruntenko,
1972; Fidler, 1974; Carnaud et al., 1974;
Umiel and Trainin, 1974). However, in
the present case, the effect of the trans-
ferred leucocyte populations may not be
merely the result of direct interaction of
leucocytes on tumour cells, since the
inoculation of leucocytes was made 24 h
prior to tumour inoculation and by a dif-
ferent route from the neoplastic cells. In
effect, while the immunocapability of the
recipient neonatal mice appears very poor
(Adler, Takiguchi and Smith, 1971) it is
possible that the transferred leucocytes
primarily act by modulating in different
ways the immunological reactivity of the
recipients.
In this case, different numbers of the
various leucocyte populations transferred
may enhance or overcome the host T-cell
suppressor activity which seems to play a
dominant role in determining the immune
reactivity of the newborn mice (Mosier
and Johnson, 1975). In this regard,
several recent studies have emphasized
the role of different suppressor cells in the
inhibition of the cytotoxic response to
tumour-associated antigens (Kirchner et
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al., 1974; Gershon, Birnbaum Mokyr
and Mitchell, 1974).
Alternatively, various ratios of trans-
ferred leucocyte populations may selec-
tively promotetheproduction ofenhancing
serum factors. However, previous studies
from this laboratory showed that soluble
serum factors seem not to play a deter-
minant role in enhancing MOPC-460
growth in syngeneic adult hosts (Forni
and Comoglio, 1974).
It might also be possible that the
administration to neonates ofmany viable
leucocytes brings into play homoeostatic
mechanisms which suppress the activity
of leucopoietic stem cells in general and
malignant plasmablasts in particular.
However, comparable experiments with
non-lymphoid tumours such as a
syngeneic sarcoma and a mammary adeno-
carcinoma (both spontaneous), showed
that similar patterns of blocking and
enhancement can be obtained in tumours
of different histology and aetiology, while
different leucocyte numbers were required
to reproduce the biphasic activity (Forni
and Giovarelli, in preparation).
At present, the mechanisms by which
the various cellular interactions block or
enhance MOPC-460 growth in the new-
born recipients is not clear. Further
analysis is required, both in vivo and in
vitro, using highly purified cellular popula-
tions, to understand how the different
leucocytes modify specifically or not the
immunocapability of newborn mice. In
any case, our results show that, on trans-
ferring increasing amounts of some leuco-
cyte populations from normal donors into
neonatal recipients, a critical level is
reached, below which there is a marked
stimulation, and above which there is a
block of tumour growth.
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